Conjugates between monoclonal antibodies to HBsAg and cytosine arabinoside.

No abstract is available for this paper.

• Publication year

  1986

• Venue

  Journal of Hepatology

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0168-8278(86)80105-2PMID 3036937
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Human hepatoma‐associated cell surface antigen: Identification and characterization by means of monoclonal antibodies

  1985cited by this paper
• Comparative efficacy of adenine arabinoside 5' monophosphate and prednisone withdrawal followed by adenine arabinoside 5' monophosphate in the treatment of chronic active hepatitis type B.

  1985cited by this paper
• Randomized controlled trial of adenine arabinoside monophosphate for chronic type B hepatitis.

  1984cited by this paper
• Antiviral Treatment of Chronic Hepatitis B Virus Infection

  1984cited by this paper
• Vidarabine monophosphate and human leukocyte interferon in chronic hepatitis B infection.

  1982cited by this paper
• Immunotherapy in nude mice of human hepatoma using monoclonal antibodies against hepatitis B virus

  1982cited by this paper
• Effect of a conjugate of daunomycin and antibodies to rat alpha-fetoprotein on the growth of alpha-fetoprotein-producing tumor cells.

  1982cited by this paper
• Successful treatment of HBs and HBeAg positive chronic liver disease: prolonged inhibition of viral replication by highly soluble adenine arabinoside 5'-monophosphate (ARA-AMP).

  1982cited by this paper
• Selecting binding and complement-mediated lysis of human hepatoma cells (PLC/PRF/5) in culture by monoclonal antibodies to hepatitis B surface antigen.

  1982cited by this paper
• Antiviral treatment of chronic hepatitis B virus infection. I. Changes in viral markers with interferon combined with adenine arabinoside.

  1981cited by this paper
• Adenine arabinoside therapy in HBsAg-positive chronic liver disease: a controlled study.

  1981cited by this paper
• Tumorigenicity in nude mice of a human hepatoma cell line containing hepatitis B virus DNA.

  1981cited by this paper
• Antiviral agents as adjuncts in cancer chemotherapy.

  1980cited by this paper
• Absence of HeLa cell contamination in 169 cell lines derived from human tumors.

  1977cited by this paper

• Targeting Hepatitis B Therapy to the Liver

  1996cites this paper
• Promedicaments macromoleculaires d'analogues de nucleotides

  1996cites this paper
• Targeting hepatitis B therapy to the liver. Clinical pharmacokinetic considerations.

  1996cites this paper
• Specific targeting of adriamycin conjugates with monoclonal antibodies to hepatoma associated antigens to intrahepatic tumors in athymic mice

  1995cites this paper
• Targeting of Drugs to the Liver

  1995cites this paper
• Human Hepatoma Associated Antigens: Opportunities for Immunotherapy

  1994cites this paper
• Determination of Degree of Substitution of Formyl Groups in Polyaldehyde Dextran by the Hydroxylamine Hydrochloride Method

  1991cites this paper
• Metabolism of pyrimidine analogues and their nucleosides.

  1990cites this paper
• 5-Iodo-2′-Deoxyuridine-Protein Conjugates: Synthesis and Enzymatic Degradation

  1990cites this paper
• Treatment of acute and chronic viral hepatitis.

  1989cites this paper
• Chapter 16. Chemical Modification of Antibodies for Cancer Chemotherapy

  1988cites this paper
• Chronic hepatitis: pathogenesis and treatment.

  1988cites this paper